It is possible that Jag1/2-mediated Notch signaling exerts distinct functions at different stages of ESCC carcinogenesis, which is suppressing the onset of ESCC while promoting its progression. The gene discussed is JAG1; the disease is esophageal squamous cell carcinoma.